Status:
COMPLETED
Endometrial Dating by Ex-vivo Imaging of Endometrial Biopsies of In-vitro Fertilization Candidate Participants
Lead Sponsor:
Fertigo Medical Ltd
Collaborating Sponsors:
Kaplan Medical Center
Conditions:
Endometrium
Eligibility:
FEMALE
18-40 years
Brief Summary
To evaluate the correlation between cycle day determination by clinical signs, study participant testimony, endometrium histopathology biopsy and ex-vivo imaging of the uterus endometrium.
Detailed Description
In order to assess the efficacy of using ex-vivo endometrial imaging to determine optimal time for embryo transfer, two to four separate analyses, including imaging, and the current standard method of...
Eligibility Criteria
Inclusion
- Gender: Female
- Age: 18-40
- Belong to one of the three following groups:
- Women undergoing fertility treatment, and are regularly ovulating
- Women whose fertility status is unknown
- Women proved to be fertile (previous spontaneous successful pregnancy)
Exclusion
- Women with known existing endometrial pathology
- Women with known history of infertility due to oligo-ovulation or anovulation.
- Women with medical history of malignant tumors in their reproductive system
- Women that are on any hormonal medications or treatments (excluding hormonal contraception in previous cycles)
- Women that are on hormonal contraception treatment in their current cycle
- Women with intrauterine device
- Women menstruating on the day of the biopsy collection
Key Trial Info
Start Date :
June 16 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 6 2021
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT04288843
Start Date
June 16 2019
End Date
June 6 2021
Last Update
February 23 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center
Petah Tikva, Israel
2
Kaplan Medical Center
Rehovot, Israel